EWLU.US Merion Inc
- Market cap
- USD 6.23K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2022.
Is EWLU.US undervalued?
Graham numberThe Graham number of Merion Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Merion Inc fundamental analysis
No fundamental analysis for Merion Inc yet.
Merion Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Merion Inc
Merion, Inc. provides health and nutritional supplements, and personal care products in the People's Republic of China and the United States. The company offers Noir Naturel, a gentle formula for grey coverage from the first application into hair; natural aphrodisiac supplements, Viwooba (1-3) for men; Lady-S, a female dietary supplement that assists on weight loss; Gold King, a nutritional supplement that provides antioxidant support and liver health; New Power, a nutrition…
Full company profileMerion Inc financial statements
2022 annualized: Fiscal year 2022 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2022, the balance sheet is the latest quarter. Figures change when the annual report is published.
Merion Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 6.83M | 379K | 911K | 760K | 379K | 1.81M | 439K | 1.48M | 455K |
| Gross Profit | 6.22M | 34.6K | 636K | 603K | 21.0K | 1.52M | -15.3K | 446K | 176K |
| Operating Income | 2.81M | -3.19M | -677K | -714K | -2.37M | -913K | -1.83M | -1.09M | -1.11M |
| EBITDA | - | - | - | -930K | -2.91M | -474K | -1.41M | -931K | -989K |
| Net Income | -1.07M | -3.49M | -737K | -1.04M | -3.15M | -722K | -1.82M | -1.20M | -1.26M |
| EPS | - | - | - | -0.01 | -0.02 | 0.00 | -0.01 | -0.02 | -0.02 |
| Balance Sheet | |||||||||
| Total Assets | 28.3M | 413K | 267K | 207K | 807K | 1.11M | 1.38M | 625K | 380K |
| Total Liabilities | 35.9M | 13.9M | 14.5M | 7.36M | 7.21M | 6.43M | 1.55M | 1.81M | 2.20M |
| Shareholders' Equity | -7.59M | -13.5M | -14.2M | -7.15M | -6.40M | -5.32M | -169K | -1.19M | -1.82M |
| Cash & Short-term Investments | 317K | 8.55K | 2.05K | 5.04K | 296K | 9.24K | 9.51K | 882.00 | 22.9K |
| Cash Flow | |||||||||
| Operating Cash Flow | -4.05M | -921K | -577K | -669K | -1.51M | -1.44M | -990K | -216K | -1.00M |
| Capital Expenditure | 5.89K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | - | - | - | -669K | -1.51M | -1.44M | -990K | -216K | -1.00M |
| Ratios | |||||||||
| ROA | -3.8% | -846.8% | -275.8% | -500.3% | -390.0% | -64.9% | -131.4% | -191.5% | -331.4% |
| Net Profit Margin | -15.7% | -920.9% | -80.9% | -136.2% | -830.2% | -40.0% | -414.2% | -80.8% | -277.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Merion Inc dividends
Merion Inc has not paid dividends in the last 8 fiscal years.
Last stock split: 1:3 on Aug 5, 2021.
Who owns Merion Inc
- Insiders 45.30%
- Institutions 0.00%
- Public & others 54.70%
- Shares outstanding 62.3M
- Free float 35.4M
Merion Inc company profile
- Company name
- Merion Inc
- Ticker
- EWLU.US
- Exchange
- USA Stocks
- Sector
- Consumer Defensive
- Industry
- Food Products
- Employees
- 6
- Fiscal year end
- December
- Address
- 100 North Barranca Street, West Covina, CA, United States, 91791
- Phone
- 626 331 7570
- Website
- merionus.com
About Merion Inc
Merion, Inc. provides health and nutritional supplements, and personal care products in the People's Republic of China and the United States. The company offers Noir Naturel, a gentle formula for grey coverage from the first application into hair; natural aphrodisiac supplements, Viwooba (1-3) for men; Lady-S, a female dietary supplement that assists on weight loss; Gold King, a nutritional supplement that provides antioxidant support and liver health; New Power, a nutritional supplement, which supports heart health; Taibao, a nutritional supplement that enhances physical performance and energy metabolism; and ReMage Power, a nutritional supplement that provides anti-aging Nicotinamide adenine dinucleotide support, as well as promotes energy and cell metabolis. It sells its products through merionus.com, as well as to wholesale distributors through phone and electronic communication. The company was formerly known as E-World USA Holding, Inc. and changed its name to Merion, Inc. in June 2017. Merion, Inc. was founded in 2007 and is headquartered in West Covina, California.
Merion Inc management
3- Mr. Ding Hua WangChairman, CEO, CFO & President · born 1964
- Ms. Vickie HoExecutive Vice President · born 1982
- Mr. Zhang JirenTechnical Director